Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease

NeuroReport

Volumn 8, Issue 8, 1997, Pages 1845-1849

  Riekkinen Jr , Paavo ^a   Riekkinen, Minna ^a   Soininen, Hilkka ^a   Kuikka, Jyrki ^a   Laakso, Mikko ^a   Riekkinen Sr , Paavo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Attention; Frontal lobe; Tetrahydroaminoacridine

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; TACRINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ATTENTION; BRAIN SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FRONTAL LOBE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REACTION TIME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TAKIN; TASK PERFORMANCE;

EID: 8544275866     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199705260-00011     Document Type: Article

References (14)

1. Whitehouse P, Price DL, Struble RG et al. Science 215, 1237-1239 (1982).
2. Bowen DM, Smith CB, White P et al. Brain 99, 459-496 (1976).
3. Francis PT, Cross AJ and Bowen DM. Neurotransmitters and neuropeptides. In: Terry RD, Katzman R, Bick KL, eds, Alzheimer Disease. 1994: 247-261.
4. Soininen H, Kosunen O, Helisalmi S et al. Neurosci Lett 187, 79-82 (1995).
5. Drachman DA, Noffsinger D, Sahakian BJ et al. Neurobiol Aging 1, 39-43 (1980).
6. Sahakian BJ, Owen AM, Morant NJ et al. Psychopharmacology 110, 395-401 (1993).
7. Laakso M, Soininen H, Partanen J et al. J Neural Transm 9, 73-86 (1995).
8. Riekkinen P Jr, Kuikka J, Soininen H et al. Neurosci Lett 195, 53-56 (1995).
9. Alhainen K, Partanen J, Reinikainen K et al. Neurosci Lett 127, 113-116 (1991).
10. Alhainen K, Helkala EL and Riekkinen P. Dementia 4, 54-58 (1993).
11. Jäkälä P, Sirviö J, Jolkkonen J et al. Behav Brain Res 51, 29-40 (1992).
12. Muir JL, Everitt BJ and Robbins TW. J Neurosci 14, 2313-2326 (1994).
13. Muir JL, Everitt BJ and Robbins TW. Psychopharmacology 118, 82-92 (1995).
14. Jones GM, Sahakian BJ, Levy R et al. Psychopharmacology 108, 485-494 (1992).